DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers

作者：Sören Schnellhardt, Simon Böke, Silke Tribius, Mechthild Krause, Marlen Haderlein, Alexander Rühle, Christoph Süß, Annett Linge, Markus Hecht, Panagiotis Balermpas, Head and Neck Cancer Expert Panel of the German Society of Radiation Oncology DEGRO · 发表于：Strahlentherapie und Onkologie · 年份：2026 · DOI：10.1007/s00066-026-02511-6 · 被引用次数：3 · 研究领域：Head and Neck Cancer Studies、Esophageal Cancer Research and Treatment、Radiopharmaceutical Chemistry and Applications

first randomized phase III trials demonstrating a prognostic benefit of perioperative or adjuvant immune checkpoint inhibition (ICI) in the curative treatment of resectable locally